JCST 2011/S12: 1948-5956-10000S12-1/Special Issue 2011
doi: 10.4172/1948-5956.10000S12
SNS01- An eIF5A-based biologic with signifi cant anti-tumoral activity following systemic administration in a murine model of multiple myeloma
John E. Thompson, Catherine Taylor and Richard Dondero

  

JCST 2011/S12: 1948-5956-10000S12-2/Special Issue 2011
doi: 10.4172/1948-5956.10000S12
The MAGE protein family: Protein degradation, genome stability, and cancer
P. Ryan Potts

  

JCST 2011/S12: 1948-5956-10000S12-3/Special Issue 2011
doi: 10.4172/1948-5956.10000S12
GATA4 represses ERBB2 expression in cancer cells : a new tumor suppressor?
Jean IMBERT

  

JCST 2011/S12: 1948-5956-10000S12-4/Special Issue 2011
doi: 10.4172/1948-5956.10000S12
GUC as potential DNA topoisomerase inhibitors to reduce the growth of cervical cancer cells
Hassan Hadi Abdallah, Mohammad T.M Al-dajani, Jamal Talaat, Akeem Akiboro, Khoo Boon Yin and Nornisah Mohamed

  

JCST 2011/S12: 1948-5956-10000S12-5/Special Issue 2011
doi: 10.4172/1948-5956.10000S12
Infl uence of hypoxia on signaling pathways upon treatment with CK2 inhibitors in selected human tumor cell lines
Tine D. Rasmussen, Louise Linnebjerg Bohn Christoffersen, Olaf-Georg Issinger

  

JCST 2011/S12: 1948-5956-10000S12-6/Special Issue 2011
doi: 10.4172/1948-5956.10000S12
The small GTPase hRAB37 acts as a metastatic suppressor via inhibition of MMP/FAK/ RhoA signal in lung cancer
Yi-Ching Wang

  

JCST 2011/S12: 1948-5956-10000S12-7/Special Issue 2011
doi: 10.4172/1948-5956.10000S12
Gene Silencing in HIV-1 Latency by Polycomb Repressive Group
Kyung-Chang Kim, Hyeon Guk Kim, Tae-Young Roh, Jihwan Park, Kyung-Min Jung, Joo-Shil Lee, Sang-Yun Choi, Sung Soon Kim and Byeong-Sun Choi